We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Vibro-Acoustic Air Pressure System Clears the Airways

By HospiMedica International staff writers
Posted on 11 Dec 2019
A novel technology removes secretions from the airways of patients suffering from diseases affecting the respiratory tract.

Developed at BGN Technologies (Beer Sheva; Israel) through a collaboration between Ben-Gurion University (BGU; Beer Sheva, Israel), Cincinnati Children's Hospital (OH, USA), and other institutions, the AeroSelf system simultaneously introduces low-frequency, low-pressure, air flow oscillations and high frequency acoustic pulses into the airway and lungs. More...
At first, air pulsations dominate as they penetrate the mucus. Detachment and removal of mucus from the airway wall is then achieved by the acoustic waves, which agglomerate the mucus chunks.

To optimize the process, a software algorithm matches the required frequencies, amplitudes, duty cycle, and relative phases to the specific patient’s geometry. The system can thus treat the core of obstructive airways pathophysiology diseases, the buildup of mucus in the small airways, in a range of respiratory conditions, such as bronchiolitis, asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF). The system is especially important in the treatment of blocked airways in children, who are more susceptible to secretion obstructions due to their smaller airway cross sectional area.

“The combination of air pulsation and acoustic waves was shown to be effective in a series of lab test that simulated human airway and lungs. Our collaboration with Cincinnati Children's and BGU laid the foundation for developing this novel technique,” said Professor Ephraim Gutmark, MD, of UC. “We are now in the process of further developing a device based on a unique clinical protocol that will offer treatment superior to existing solutions.”

“Even though airway secretions are a major component in the pathophysiology of numerous serious diseases affecting the respiratory tract, there is currently no effective therapeutic modality that directly or indirectly treats the small airways,” said Professor David Katoshevski, PhD, of BGU. “Our colleagues at Cincinnati Children's brought the medical knowledge and an unmet need that was coupled with our technical and engineering capabilities. Together we developed this innovative solution in order to allow bronchiolitis, COPD, and CF patients to breathe freely.”

Related Links:
BGN Technologies
Ben-Gurion University
Cincinnati Children's Hospital



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.